Northwell Health: Bipolar Disorder trials
The registry lists 11 Bipolar Disorder studies with Northwell Health as lead sponsor. 0 are open to participants now and 3 have results posted.
Phase 3 1Phase 4 3No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in DepressionCompletedNCT01881763Phase 4Results posted
- Liothyronine (T3) for Bipolar DepressionCompletedNCT00790738Phase 3Results posted
- Cognitive Enhancement in Bipolar DisorderCompletedNCT00597896Phase 4Results posted
- Financial Incentives to Improve Medication AdherenceCompletedNCT04191876Not applicable
- Emotion Recognition Modification for Bipolar DisorderWithdrawnNCT02613104Not applicable
- Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase PsychosisCompletedNCT02566057Not applicable
- Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With PsychosisCompletedNCT01878513Not applicable
- Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics.CompletedNCT01786369
- Clinical Risk State for Bipolar Disorder in AdolescentsStatus unknownNCT01383915
- Bipolar Disorder in EpilepsyCompletedNCT00365482
- Treatment and Outcome of Early Onset Bipolar DisorderCompletedNCT00048802Phase 4